Navigation Links
Cultured CTCs reveal genetic profile, potential drug susceptibility of breast cancer cells
Date:7/10/2014

Circulating tumor cells captured with a microchip-based device developed at the Massachusetts General Hospital (MGH) Center for Engineering in Medicine and the MGH Cancer Center can be cultured to establish cell lines for genetic analysis and drug testing. In the July 11 issue of Science, an MGH research team reports that the cultured cells accurately reflect a tumor's genetic mutation over time and changing susceptibility to therapeutic drugs.

"We now can culture cells from the blood that represent those present in metastatic deposits, which allows testing for drug susceptibility as the tumor evolves and acquires new mutations," says Shyamala Maheswaran, PhD, of the MGH Cancer Center, co-senior author of the Science paper. "We need to improve culture techniques before this is ready for clinical use, and we are working on doing that right now."

Circulating tumor cells (CTCs) are living solid-tumor cells that break off from either a primary or metastatic tumor and are carried through the bloodstream in extremely small quantities. The current version of the MGH-developed device, called the CTC-iChip, does not rely on prior identification of marker proteins on the surface of tumor cells, a limitation of previous versions of the MGH device and of the only commercially available device for capturing CTCs. Cell-surface proteins can change as tumors mutate during metastasis or in response to treatment, raising the possibility that methods targeting specific proteins may not reveal the full spectrum of CTCs.

The current study was designed to verify the ability of the CTC-iChip first described in an April 2013 Science Translational Medicine report to capture viable CTCs in a way that enables the establishment of cell lines that accurately represent the genetic status of all existing tumor sites and can be used for the testing of therapeutic drugs. The researchers first isolated CTCs from the blood of 36 patients with met
'/>"/>

Contact: Katie Marquedant
kmarquedant@partners.org
617-726-0337
Massachusetts General Hospital
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Benefits of Cultured Vegetables and Probiotics for Immune Health Published by in new Article eProbiotics.com
2. Study reveals protective role for specialized cells in intestinal and respiratory systems
3. Infant toenails reveal in utero exposure to low-level arsenic, Dartmouth study finds
4. New study reveals how tumors remodel their surroundings to grow
5. Mayo Clinic researchers reveal treasure trove of genes key to kidney cancer
6. Unsuspected aspect of immune regulation revealed
7. Nanoscale ruler reveals organization of the cell membrane
8. Survey reveals consumers pecan preferences
9. Penn study reveals a common genetic link in fatal autoimmune skin disease
10. Seemingly invincible cancers stem cells reveal a weakness
11. First survey of ACOs reveals surprising level of physician leadership
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/26/2014)... December 26, 2014 “Many people become ... personal injury claim issues and phone calls with insurance ... an article featuring their free eBook on pedestrian ... eBook on pedestrian and bicycle auto accident claims assures ... fully capable of professionally handling their case while they ...
(Date:12/26/2014)... December 26, 2014 Parker & ... the best in heating, cooling and plumbing contractor ... hour emergency services in 2014 with regard to ... that Arizona is known for its incredibly hot ... understands the intricacies and details of a wide ...
(Date:12/25/2014)... The report “Nintedanib (Colorectal Cancer) ... on the current treatment landscape, unmet needs, current ... market. Stivarga is a drug which is used ... Boehringer Ingelheim is developing nintedanib (BIBF-1120), an orally ... CRC in the US, Europe, and Japan. The ...
(Date:12/25/2014)... December 26, 2014 Recently, iFitDress.com, the popular ... women, has announced its new selection of black one-shoulder ... on sale now; they are available at discounted prices, up ... “The promotion will last for three weeks only. You know, ... Those who are interested in our new items can visit ...
(Date:12/25/2014)... 2014 BambooFlooringChina.com sells many bamboo products ... flooring. Today, the company announces big discounts on ... and colors. , BambooFlooringChina.com is the world’s leader in ... is valid until Jan. 20, 2015. , The bamboo ... with a natural thread. All the bamboo strips for ...
Breaking Medicine News(10 mins):Health News:Guide to Handling Pedestrian and Bicycle Accidents Released By The Jones Firm, Featured in Recent Article 2Health News:Parker & Sons Announces Record Demand For 24 Hour Emergency Services In 2014 With Regard To Air-Conditioning Systems 2Health News:Parker & Sons Announces Record Demand For 24 Hour Emergency Services In 2014 With Regard To Air-Conditioning Systems 3Health News:Nintedanib Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 2Health News:Nintedanib Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 3Health News:Nintedanib Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 4Health News:iFitDress.com: Black One-Shoulder Cocktail Dresses for 2015 2Health News:Various Styles of Bamboo Mats in Many Colors from BambooFlooringChina.com 2
... By Jenifer Goodwin HealthDay Reporter , TUESDAY, ... be reduced if operating room staff borrowed team-building procedures ... A program that trained operating room workers to ... and to review what went right or wrong after ...
... By Jenifer Goodwin HealthDay Reporter , TUESDAY, ... before heart surgery suffered fewer heart attacks, stroke and ... had better survival rates, two new studies find. ... bypass, valve or other scheduled cardiac surgeries. Of those, ...
... 19, 2010A rare and deadly form of breast cancer ... is the focus of a new report from leading ... an unrecognized and misunderstood form of breast cancer. It ... has lower overall survival compared to other breast cancers. ...
... a child or a dog play is not a foreign sight. ... Apparently, they play, too. In fact, according to Gordon Burghardt, ... -- not just dogs, cats, and monkeys -- need a little ... juvenile reptiles for many years and never saw anything that I ...
... Reporter , MONDAY, Oct. 18 (HealthDay News) -- ... medical mistakes, ranging from an operation on the wrong ... a new study finds. To try to curb ... 2004 introduced a universal protocol for all hospitals, ambulatory ...
... and quality of life for older people, but is also ... The research will be presented today,s at the Scientific Program ... East-Africa Council of Ophthalmology (MEACO) Joint Meeting. Cataract surgery not ... but is also apparently a way to reduce the number ...
Cached Medicine News:Health News:Lessons From Flight Crews Can Help Surgical Teams Work Better 2Health News:Lessons From Flight Crews Can Help Surgical Teams Work Better 3Health News:Aspirin, Statins May Reduce Problems After Heart Surgery 2Health News:Aspirin, Statins May Reduce Problems After Heart Surgery 3Health News:Inflammatory breast cancer focus of new report 2Health News:UT professor defines play, discovers even turtles need recess 2Health News:Surgery on Wrong Patients, Surgical Sites Persists, Study Finds 2Health News:Surgery on Wrong Patients, Surgical Sites Persists, Study Finds 3Health News:Surgery on Wrong Patients, Surgical Sites Persists, Study Finds 4Health News:Cataract surgery saves lives, dollars by reducing auto crashes 2
(Date:12/24/2014)... 2014   Synageva BioPharma Corp. (NASDAQ: ... therapeutic products for rare disorders, today announced validation ... Marketing Authorization Application (MAA) for sebelipase alfa for ... request for accelerated assessment, which has the potential ... The MAA, and the Biologics License ...
(Date:12/24/2014)... CHENGDU, China , Dec. 23, 2014 /PRNewswire/ ... a pharmaceutical company that specializes in patented biopharmaceutical, ... active pharmaceutical ingredients (API) today announced that the ... for its Good Manufacturing Practice (GMP) certificate of ... & Drug Administration,s (CFDA). The public notice period ...
(Date:12/22/2014)... 22, 2014  CytoSorbents Corporation (OTCQB:CTSOD), a critical ... purification technology to help fight deadly inflammation in ... worldwide, today announced the appointment of Dr. ... its Senior Vice President of Clinical Development, effective ... Di Russo is an accomplished pediatric cardiothoracic ...
Breaking Medicine Technology:Synageva BioPharma Announces Sebelipase Alfa Marketing Authorization Application Validated By The EMA 2Synageva BioPharma Announces Sebelipase Alfa Marketing Authorization Application Validated By The EMA 3TPI QLF Achieved Public Notice Status of GMP Certification 2TPI QLF Achieved Public Notice Status of GMP Certification 3CytoSorbents Appoints Dr. Gregory B. Di Russo as Senior Vice President of Clinical Development 2CytoSorbents Appoints Dr. Gregory B. Di Russo as Senior Vice President of Clinical Development 3CytoSorbents Appoints Dr. Gregory B. Di Russo as Senior Vice President of Clinical Development 4CytoSorbents Appoints Dr. Gregory B. Di Russo as Senior Vice President of Clinical Development 5
... Size: 5.0 x 2.5 x 80 mm. Half ... by Harvey A. Lincoff, M.D. has been modified ... design. The material is a closed cell sponge ... with rounded edges to minimize scleral intrusion. These ...
For use under curved implants. Indications: When additional buckling is required in the meridional direction. Overall length: 15.0 mm....
For use with E5381 600 Circling Band (40 style)....
Ungrooved permanent silicone strip. Indications: For trapdoor procedure. Overall length: 125 mm, 4.9 inches....
Medicine Products: